Iodothyronine 5′ deiodinase, which is mainly responsible for peripheral T3 production, has recently been demonstrated to be a selenium (Se)-containing enzyme. The structure of nuclear thyroid hormone receptors contains Zinc (Zn) ions, crucial for the functional properties of the protein. In the elderly, reduced peripheral conversion of T4 to T3 with a lower T3/T4 ratio and overt hypothyroidism are frequently observed. We measured serum Se and RBC GSH-Px (as indices of Se status), circulating and RBC Zinc (as indices of Zn status), thyroid hormones and TSH in 109 healthy euthyroid subjects (52 women, 57 men), carefully selected to avoid abnormally low thyroid hormone levels induced by acute or chronic diseases or calorie restriction. The subjects were subdivided into three age groups. To avoid under- or malnutrition conditions, dietary records were obtained for a sample of 24 subjects, randomly selected and representative of the whole population for age and sex. Low T3/T4 ratios and reduced Se and RBC GSH-Px activity were observed only in the older group. A highly significant linear correlation between the T3/T4 ratio and indices of Se status was observed in the older group of subjects (r=0.54;p<0.002, for Se;r=0.50;p<0.002, for RBC GSH-Px). Indices of Zn status did not correlate with thyroid hormones, but RBC Zn was decreased in older as compared with younger subjects. We concluded that reduced peripheral T4 conversion is related to impaired Se status in the elderly.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
J. H. Oppenheimer, D. Koerner, H. L. Schwartz, and M. I. Surks, Specific nuclear triodothyronine binding sites in rat liver and kidney,J. Clin. Endocrinol. 35, 330–333 (1972).
G. A. Brent, D. D. Moore, and P. R. Larsen, Thyroid hormone regulation of gene expression,Annu. Rev. Physiol. 53, 17–35 (1991).
T. Miyamoto, A. Sakurai, and L. De Groot, Effects of zinc and other divalent metals on deoxyribonucleic acid binding and hormone-binding activity of human α1 thyroid hormone receptor expressed in Escherichia coli,Endocrinology 129, 3027–3033 (1991).
H. C. Freake, Molecular biological approaches to studying trace minerals: why should clinicians care?,J. Am. Coll. Nutr. 12, 294–302 (1993).
J. Kohrle, R. D. Hesch, and J. L. Leonard, Intracellular pathways of iodothyronine metabolism, inThe Thyroid, L. E. Braverman and R. D. Utiger, eds., Lippincott, Philadelphia, pp. 144–189 (1991).
D. Behne, A. Kyriakopoulos, H. Meinhold, and J. Kohrle, Identification of type-I iodothyronine 5′-deiodinase as a selenoenzyme,Biochem. Biophys. Res. Commun. 173, 1143–1149 (1990).
M. J. Berry, L. Banu, and P. R. Larsen, Type-I iodothyronine deiodinase is a selenocysteine-containing enzyme.Nature 349, 438–440 (1991).
G. J. Beckett, S. E. Beddows, P. C. Morrice, F. Nicol, and J. R. Arthur, Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats,Biochem J. 248, 443–447 (1987).
G. J. Beckett, D. A. MacDougall, F. Nicol, and J. R. Arthur, Inhibition of type I and type II deiodinase activity in rat liver, kidney and brain produced by selenium deficiency,Biochem J. 259, 887–892 (1989).
B. Contempré, J. E. Dumont, B. Ngo, C. H. Thilly, A. T. Diplock, and J. Vanderpas, Effects of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium,J. Clin. Endocrinol. Metab. 73, 213–215 (1991).
B. Contempré, N. L. Duale, J. E. Dumont, B. Ngo, A. T. Diplock, and J. Vanderpas, Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population,Clin. Endocrinol. 36, 579–583 (1992).
E. Roti, R. Minelli, E. Gardini, L. Bianconi, A. Ronchi, A. Gatti, and C. Minoia, Selenium administration does not cause thyroid insufficiency in subjects with mild iodine deficiency and sufficient selenium intake.J. Endocrinol. Invest. 16, 481–484 (1993).
P. Rae, J. Farrar, G. Beckett, and A. Toft, Assesment of thyroid status in elderly people,Br. Med. J. 307, 177–180 (1993).
S. H. Ingbar, The thyroid gland, inTextbook of Endocrinology, J. D. Wilson and D. W. Foster, eds., Saunders, Philadelphia, pp. 682–815 (1985).
G. Lockitch, Selenium: clinical significance and analytical concepts,Crit. Rev Clin. Lab. Sci. 27, 483–541 (1989).
G. C. Zucchelli, A. Pilo, S. Masini, M. R. Chiesa, and C. Prontera, A new chemiluminescence immunoassay for triiodothyronine and thyroxine: evaluation using quality control sera assayed in an interlaboratory survey.J. Clin. Chem. Clin. Biochem.,28, 193–197 (1990).
D. Girelli, O. Olivieri, A. M. Stanzial, M. Azzini, A. Lupo, P. Bernich C. Menini, L. Gammaro, and R. Corrocher, Low platelet glutathione peroxidase and serum selenium in chronic renal failure patients: relations to dialysis treatments, diet and cardiovascular complications,Clin. Sci. 84, 611–617 (1993).
N. W. Solomons, On the assessment of zinc and copper nutriture in man,Am. J. Clin. Nutr. 32, 856–871 (1979).
J. Reglinski, W. E. Smith, R. Wilson, D. J. Halls, J. H. McKillop, and J. A. Thomson, Selenium in Graves’ disease (letter),Clin. Chim. Acta 211, 189–190 (1992).
J. R. Arthur, F. Nicol, and G. J. Beckett, Selenium deficiency, thyroid hormone metabolism, and thyroid hormone deiodinases,Am. J. Clin. Nutr. 57(2 suppl.), 236S-239S (1993).
G. J. Beckett, F. Nicol, P. W. H Rae, S. Beech, Y. Guo, and J. R. Arthur, Effects of combined iodine and selenium deficiency on thyroid hormone metabolism in rats,Am. J. Clin. Nutr. 57(2 suppl), 240S-243S (1993).
S. Vadhanavikit and H. E. Ganther, Selenium requirements of rats for normal hepatic and thyroidal 5′-deiodinase (type I) activities,J. Nutr. 123, 1124–1128 (1993).
J. Chanoine, L. E. Braverman, A. P. Farwell, M. Safran, S. Alex, S. Dubord, and J. L. Leonard, The thyroid gland is a major source of circulating T3 in the rat,J. Clin. Invest. 91, 2709–2713 (1993).
W. Terwolbeck, D. Behne, H. Meinhold, H. Menzel, and I. Lombeck, Increased plasma T4-levels in children with low selenium state due to reduced type I iodothyronine 5′-deiodinase activity,J. Trace Elem. Electrolytes Health. Dis. 7, 53–55 (1993).
M. J. Berry, D. Grieco, B. A. Taylor, A. L. Maia, J. D. Kieffer, W. Beamer, E. Glover, A. Poland, and P. R. Larsen, Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5′-deiodinase deficiency,J. Clin. Invest. 92, 1517–1528 (1993).
D. Hartman, The aging process,Proc. Natl. Acad. Sci. USA 78, 7124–7128 (1981).
About this article
Cite this article
Olivieri, O., Girelli, D., Stanzial, A.M. et al. Selenium, zinc, and thyroid hormones in healthy subjects. Biol Trace Elem Res 51, 31–41 (1996). https://doi.org/10.1007/BF02790145
- glutathione peroxidase
- thyroid hormones